NO138564C - Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(2-carboxy-chromon-5-yloxy)-2-(hydroxy)-3-(p-cyanfenoxy) propan eller derivater herav - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(2-carboxy-chromon-5-yloxy)-2-(hydroxy)-3-(p-cyanfenoxy) propan eller derivater heravInfo
- Publication number
- NO138564C NO138564C NO144/73A NO14473A NO138564C NO 138564 C NO138564 C NO 138564C NO 144/73 A NO144/73 A NO 144/73A NO 14473 A NO14473 A NO 14473A NO 138564 C NO138564 C NO 138564C
- Authority
- NO
- Norway
- Prior art keywords
- cyanfenoxy
- chromon
- yloxy
- carboxy
- propane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB191272A GB1405253A (en) | 1972-01-14 | 1972-01-14 | 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO138564B NO138564B (no) | 1978-06-19 |
NO138564C true NO138564C (no) | 1978-09-27 |
Family
ID=9730211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO144/73A NO138564C (no) | 1972-01-14 | 1973-01-12 | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(2-carboxy-chromon-5-yloxy)-2-(hydroxy)-3-(p-cyanfenoxy) propan eller derivater herav |
Country Status (19)
Country | Link |
---|---|
US (1) | US3899513A (fr) |
JP (1) | JPS5411310B2 (fr) |
AR (1) | AR194869A1 (fr) |
BE (1) | BE793969A (fr) |
BR (1) | BR7300291D0 (fr) |
CA (1) | CA1010883A (fr) |
CH (1) | CH585702A5 (fr) |
DE (1) | DE2301541A1 (fr) |
DK (1) | DK135349C (fr) |
ES (1) | ES410559A1 (fr) |
FR (1) | FR2181667B1 (fr) |
GB (1) | GB1405253A (fr) |
HU (1) | HU164946B (fr) |
IL (1) | IL41227A (fr) |
NL (1) | NL7300408A (fr) |
NO (1) | NO138564C (fr) |
SE (1) | SE396387B (fr) |
SU (1) | SU469247A3 (fr) |
ZA (1) | ZA7358B (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567201A (en) * | 1981-11-25 | 1986-01-28 | Takeda Chemical Industries, Ltd. | Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof |
US5135940A (en) * | 1982-09-23 | 1992-08-04 | Merck Frosst Canada, Inc. | Leukotriene antagonists |
US4661505A (en) * | 1982-11-03 | 1987-04-28 | Eli Lilly And Company | Leukotriene antagonists |
US4820867A (en) * | 1983-04-21 | 1989-04-11 | Merck Frosst Canada, Inc. | Phenoxypropoxy halophenylacetic acids as leukotriene antagonists |
ZA844519B (en) * | 1983-06-24 | 1985-02-27 | Hoffmann La Roche | Dihydrobenzopyran derivatives |
US5105017A (en) * | 1983-07-18 | 1992-04-14 | Eli Lilly And Company | Leukotriene antagonist intermediates |
US4874777A (en) * | 1987-04-10 | 1989-10-17 | Eli Lilly And Company | Leukotriene antagonists |
US4853398A (en) * | 1987-04-13 | 1989-08-01 | Eli Lilly And Company | Leukotriene antagonists and use thereas |
US5352690A (en) * | 1992-07-01 | 1994-10-04 | Eli Lilly And Company | 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists |
KR100783255B1 (ko) | 2004-02-13 | 2007-12-06 | 워너-램버트 캄파니 엘엘씨 | 안드로젠 수용체 조절제 |
US7507860B2 (en) | 2004-04-13 | 2009-03-24 | Pfizer Inc. | Androgen modulators |
BRPI0509980A (pt) * | 2004-04-22 | 2007-10-16 | Warner Lambert Co | moduladores de androgênio |
MXPA06015169A (es) | 2004-07-08 | 2007-08-21 | Warner Lambert Co | Moduladores de androgenos. |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1144905A (en) * | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
GB1190193A (en) * | 1966-07-05 | 1970-04-29 | Fisons Pharmaceuticals Ltd | Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof |
GB1292601A (en) * | 1968-10-30 | 1972-10-11 | Fisons Pharmaceuticals Ltd | Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them |
GB1290174A (fr) * | 1969-05-20 | 1972-09-20 | Fisons Pharmaceuticals Ltd | |
US3823165A (en) * | 1969-10-28 | 1974-07-09 | Fisons Ltd | Pharmaceutically active compounds |
-
1972
- 1972-01-12 SU SU1873458A patent/SU469247A3/ru active
- 1972-01-14 GB GB191272A patent/GB1405253A/en not_active Expired
-
1973
- 1973-01-02 US US320600A patent/US3899513A/en not_active Expired - Lifetime
- 1973-01-02 CA CA160,351A patent/CA1010883A/en not_active Expired
- 1973-01-03 IL IL41227A patent/IL41227A/en unknown
- 1973-01-11 NL NL7300408A patent/NL7300408A/xx not_active Application Discontinuation
- 1973-01-11 FR FR7300929A patent/FR2181667B1/fr not_active Expired
- 1973-01-12 DE DE2301541A patent/DE2301541A1/de active Pending
- 1973-01-12 ES ES410559A patent/ES410559A1/es not_active Expired
- 1973-01-12 DK DK19473A patent/DK135349C/da active
- 1973-01-12 BR BR73291A patent/BR7300291D0/pt unknown
- 1973-01-12 HU HUMI520A patent/HU164946B/hu unknown
- 1973-01-12 SE SE7300461A patent/SE396387B/xx unknown
- 1973-01-12 CH CH45073A patent/CH585702A5/xx not_active IP Right Cessation
- 1973-01-12 NO NO144/73A patent/NO138564C/no unknown
- 1973-01-12 BE BE793969D patent/BE793969A/fr unknown
- 1973-01-12 AR AR246100A patent/AR194869A1/es active
- 1973-01-13 ZA ZA730058A patent/ZA7358B/xx unknown
- 1973-01-13 JP JP699473A patent/JPS5411310B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB1405253A (en) | 1975-09-10 |
DK135349C (da) | 1977-09-26 |
SE396387B (sv) | 1977-09-19 |
AR194869A1 (es) | 1973-08-24 |
NL7300408A (fr) | 1973-07-17 |
CA1010883A (en) | 1977-05-24 |
FR2181667B1 (fr) | 1976-09-03 |
US3899513A (en) | 1975-08-12 |
JPS5411310B2 (fr) | 1979-05-14 |
IL41227A (en) | 1976-08-31 |
CH585702A5 (fr) | 1977-03-15 |
SU469247A3 (ru) | 1975-04-30 |
DK135349B (da) | 1977-04-12 |
ZA7358B (en) | 1973-10-31 |
BR7300291D0 (pt) | 1973-10-25 |
BE793969A (fr) | 1973-05-02 |
JPS4878171A (fr) | 1973-10-20 |
HU164946B (fr) | 1974-05-28 |
IL41227A0 (en) | 1973-03-30 |
DE2301541A1 (de) | 1973-09-06 |
NO138564B (no) | 1978-06-19 |
ES410559A1 (es) | 1976-05-01 |
FR2181667A1 (fr) | 1973-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO140056C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive olefinisk 4-substituerte piperidino-derivater | |
NO793013L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
NO140381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner | |
NO138807C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivr e 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporine | |
NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
NO138335C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer | |
NO137941C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin | |
NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
NO138566C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater | |
NO138564C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(2-carboxy-chromon-5-yloxy)-2-(hydroxy)-3-(p-cyanfenoxy) propan eller derivater herav | |
NO143575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater | |
NO138532C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-(4-fenoksy-fenyl)-1,3,5-triazin-derivater | |
NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
NO140977C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner | |
NO139685C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater | |
NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
NO137899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider | |
NO140670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater | |
NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
NO139088C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner | |
NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
NO138025C (no) | Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler | |
NO139050C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater | |
NO138568C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 21-(bea-benzoylaminoisobutyryl)-16alfa,17alfa-(p-dimethyl-aminobenzyliden)-triamcinolon |